Hospital Acquired Pneumonia Clinical Trial
Official title:
Use of Early Mobilisation to Reduce Incidence of Hospital Acquired Pneumonia in Medical Inpatients
Hospital acquired pneumonia (HAP) is a common complication of extended hospital stay. In
surgical specialities and critical care early physiotherapy is a recognised way of
preventing such infections, and reducing length of hospital stay (LOS), however prevention
of this problem is less well studied in medical inpatients.
The investigators propose a pilot study to assess the impact of introducing an early
mobilisation strategy to general medical and respiratory wards at an acute Trust in the
United Kingdom (UK). The investigators will recruit all new admissions to each of 2
respiratory and 2 elderly care wards - 1 of each ward type will be allocated to receive
extra physiotherapy input targeting new admissions for early mobilisation. Patients' usual
mobility, current mobility and actual activity levels will be studied by accelerometer and
simple patient questionnaire in the first 48 hours of admission, and compared between
groups. Incidence of HAP and total LOS will be recorded and compared between groups.
The investigators hypotheses are that the physiotherapy intervention will increase activity
levels, reduce incidence of HAP and reduce LOS. The latter may result in cost savings to the
National Health Service (NHS), which the investigators will model using local tariff data.
The investigators plan to use our data to power a larger randomised controlled study, or if
the intervention is a marked success, such that a control group would be unethical, then a
wider service development and evaluation programme.
n/a
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03348579 -
Hospital-acquired Pneumonia in Intensive Care Unit
|
||
| Completed |
NCT02454114 -
HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections
|
N/A | |
| Recruiting |
NCT05487586 -
Real-World Study of Ceftazidime Avibactam in China
|
||
| Completed |
NCT01577862 -
Colistin and Rifampicin for MDR-Acinetobacter
|
Phase 3 | |
| Completed |
NCT03039998 -
Validity of Biological Material Sampling in Patients With Hospital-acquired Pneumonia
|
N/A | |
| Completed |
NCT01883869 -
Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor
|
Phase 1 | |
| Recruiting |
NCT02203110 -
The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe Pneumonia
|
N/A | |
| Not yet recruiting |
NCT06269900 -
Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype
|
Phase 3 | |
| Completed |
NCT04882085 -
Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
|
Phase 4 | |
| Completed |
NCT02058004 -
Does Cricoid Pressure Reduce the Risk of Aspiration?
|
N/A |